Ignite Creation Date:
2025-12-25 @ 1:45 AM
Ignite Modification Date:
2025-12-27 @ 11:39 PM
Study NCT ID:
NCT03786094
Status:
TERMINATED
Last Update Posted:
2023-11-01
First Post:
2018-12-20
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Pivotal Study in HER2 Negative, Locally Recurrent or Metastatic Breast Cancer
Sponsor:
Spexis AG
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-05-30
Start Date Type:
ACTUAL
Primary Completion Date:
2021-10-19
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-10-19
Completion Date Type:
ACTUAL
First Submit Date:
2018-12-20
First Submit QC Date:
None
Study First Post Date:
2018-12-24
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-09-19
Results First Submit QC Date:
None
Results First Post Date:
2023-11-01
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-10-30
Last Update Post Date:
2023-11-01
Last Update Post Date Type:
ACTUAL